SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors
NCT02840149
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
68Ga-DOTATATE PET/CT
Sponsor
Jewish General Hospital